“…It is a measure of the importance of continuing the Japanese atomic bomb survivor cohort that a new set of dose estimates for the cohort, the so-called DS02 dosimetry, has been recently developed, funded at great expense primarily by the US and Japanese governments and approved for use at RERF by senior committees of both countries (Roessler 2003). The DS02 dosimetry, although (as it turned out) not substantially different from the previous (DS86) dose estimates, largely resolved apparent contradictions with thermal neutron dose activation measurements (Cullings and Fujita 2003, Huber et al 2003, Straume et al 2003 and thus validated in large part the estimates of radiation risk ascribed to gamma rays, the more relevant exposure to workers and, to a lesser extent, the general population.…”